electroCore Expands Intellectual Property Portfolio; Trademark Office Has Issued A Patent Related To Systems And Methods For Treating Post-traumatic Stress Disorder
Portfolio Pulse from Benzinga Newsdesk
electroCore, Inc. (NASDAQ:ECOR) has been granted a U.S. patent for systems and methods to treat PTSD using vagal nerve stimulation. The patent, U.S. Patent No. 11,865,329, covers the application of electrical impulses to the vagus nerve for 90 seconds to 3 minutes, which may consist of bursts of 2 to 20 pulses.
January 09, 2024 | 1:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
electroCore has been awarded a patent for a PTSD treatment method, potentially strengthening its product portfolio and market position.
The issuance of a new patent typically provides a company with exclusive rights to their innovation, which can protect and potentially enhance their competitive edge. For electroCore, this patent may lead to the development of new products, increase its intellectual property value, and attract investor interest. The patent is directly related to the company's core business, making this news highly relevant and important for investors. The positive score reflects the potential for stock price appreciation in the short term due to this development.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100